DLCO
Dr Athul Francis
JR-II
Pulmonary Medicine
DLCO-Measures the efficiency of lung in transporting oxygen
across the alveolar capillary membrane
Also known as Transfer Factor
measurement of CO uptake reflects a no. of processes(not
just diffusion) and it submaximal values ,hence its not truly
a capacity
Assessment of gas exchanging ability of the lung
Carbon Monoxide Diffusing Capacity
 Transfer of Carbon Monoxide – Diffusion Limited
 Unit: ml of CO/minute/mm /Hg
 0 degree Celsius,760 mm Hg ,dry
 STPD-Standard Temperature Pressure Dry
Why is CO used ??
 CO combines with Hb about 210 times more readily than
oxygen
 Diffusion Limited transfer
 Limited/no CO in blood/alveoli
Components of Diffusion Pathway
Gas space within the alveolus
• Tissue barrier – alveolar capillary membrane
• Alveolar lining fluid – surfactant rich
• Plasma layer
• Diffusion into and within the RBC
• Uptake of CO by hemoglobin


Methods Of DLCO measurement
 1.Single breath Hold
 2.Rebreathing Method
 3.Intrabreath Method
 4.Steady State Method
Single Breath Hold –Modified Krogh’s
 Before Starting the procedure :
 A) Calibrate the equipment
 B) Enter the necessary Data
 C) Enter Hb levels
 Place the Subject in sitting Down Position
 Adjust the mouth piece to proper position
 Seal the lips firmly around mouthpiece
Indications
Most commonly used in evaluation of
 diffuse interstitial lesions
 suspected emphysema
 pulmonary vascular obstruction
 Monitoring of Drug Therapy –Amiodarone
Useful in diagnosis as well as follow up
Diffusing Capacity
DLcosb
Pretest Patient Preparation
Should refrain from:
Smoking for at least 24 hours prior to testing
Consuming alcohol 4 hours prior to test (will
reduce DLco)
Strenuous exercise before testing (effects
pulmonary capillary blood volume)
Eating for at least two hours prior to testing
(digestion effects pulmonary capillary blood
volume)
Diffusing Capacity
Pretest Patient Preparation
o Should sit for at least 5 minutes
before test (effects pulmonary
capillary blood volume)
o Supplemental O2 should be
discontinued at least five minutes
prior to testing
SINGLE BREATH METHOD
Breathing maneuvers reqd :
Tidal breathing for few breaths
Unforced expiration to RV
Single forced inspiration.
Breathhold for 8-12 sec
Rapid expiration
o Inspiratory gas mixture contain 0.3%CO and an inert gas
10%He.
o Rapid exhalation time of <4sec &sample collection of no
more than 3sec.are required.
o Initial portion of expirate containing dead space is
discarded ;remainder is collected & conc. of CO & He are
measured.
Procedure
Unforced exhalation to RV
(limited to 6 seconds)
Rapid inhalation of a diffusion gas mixture to TLC (from spirometer/demand
valve/reservoir)
0.3% CO
10% He (tracer gas)
21% O2
Balance Nitrogen
Breath hold at TLC for 10 +/- 2 seconds
Rapid exhalation
(should not exceed 4 sec)
Alveolar gas is collected after a washout volume
(0.75-1.0 L) has been discarded
(If VC is <2.0 L, washout volume may be reduced to 0.50L)
Sample gas volume should be 0.50 – 1.0 L
(If VC <1.0L, a sample of <0.50L can be analyzed if deadspace
volume has been cleared)
Sample is analyzed for the fractional CO and He (tracer gas)
concentration
Change in He concentration reflects dilution by gas in lungs at RV
This change is used to determine the initial CO concentration
Summary of the procedure
Spirometry, lung volumes
Acceptability Criteria
1.System has
passed calibration
and quality
control
2.Inspiration from
RV to TLC –rapid
and within four
seconds
3.Inspired
Volume-85 % of
recorded VC
4.Breath Hold
Time between 8-
12 seconds – no
leaks , no Valsalva
5.Rapid
Exhalation-lasting
4 or less seconds
6.Interval of 4
minutes between
two episodes
7.TLC and Va is consistent with clinical finding.Tlc should be
always more than Va
8.Average of two or more tests should be reported
Duplicate values should be within 3ml/min/mm Hg of each other
or within 10 percentage of the largest value.
Average DLco value
20-30 ml CO/min/mm Hg (STPD)
Inspiratory maneuver
14%He, 18%O2, 0.27%CO)
breathhold
Deadspace washout(0.75
L)
If VC<2L, reduce to 0.5L
Sample collection
volume
0.5-1LIf VC<2L, reduce
to 0.5L
Calculation of
DLCO
DLCO = VA X ln FACOi
 T X (PB-47) FACOF
T = time of breath hold
PB = barometric pressure
47 = water vapour pressure at 37oC
KCO = DLCO
 VA
VA=alv.vol
FACOi=alv conc.@start of breath
holding.
FACOF=alv conc.@end of breath
holding
FACOi =FEHe/FIHe *FICO
FEHe=expired conc of He
FIHe=inspired conc of He
FICO=inspired conc of co
FACO final is equal to conc of co in expired gas.
Va alveolar volume is determined in 2 ways:
1)Sum of RV calculated by closed circuit He or body
plethysmography and vol of inspired gas as
recorded on spirometer.
2)Calculated from single breath dilution of He that
occur during determination of DLCO.
Equipment quality control
Gas-analyser zeroing Done before/after each test
Volume accuracy Tested daily
Standard subject or simulator testing Tested at least weekly
Gas-analyser linearity Tested every 3 months
Timer Tested every 3 months
Severity for diffusion disorders
% of predicted
Normal 80 – 100
Mild 60 – 79
Moderate 40 – 59
Severe 20 – 39
Very severe < 20
STEADY STATE METHOD
In this a gas mixture containing 0.1%CO is
breathed until the rate of CO uptake from
lung is constant.
It require no respiratory manuveres and can
be done during exercise.
It require Arterial blood sample.
It gives lower value for resting subjects than
single breath method.
Rebreathing Method
 Patient is made to rebreathe from a reservoir containing
0.3 % CO, tracer gas and air
 30-60 seconds at 30 breaths/min
 Final CO,tracer and O2 concentrations are measured.
Slow exhalation Single Breath
Intrabreath Method
 Patient inspires a VC breath of test gas containing 0.3 %
CO,21 % O2 and the balance N2
 Patient exhales slowly – 0.5L/sec from TLC to RV.
 CH4 used as the tracer gas
Normal values of DLCO and corrected
DLCO
 Normal Value: 20-30 ml CO/min/mm Hg
 Normal Value depends on :
 Age –decreases as age increases
 Sex-lower in females
 Size-taller people-larger lung –higher DLCO
 Alveolar volume-measured with the help of helium
 DLCO/Va –normalizes the DLCO for various sizes
 Also known as Krogh Constant
Corrected DLCO

 2.Correction for COHb : DLCO X (102 %-CoHb %)
 3.Correction for altitude and PAO2
 DLCO for altitude= DLCO /( 1+0.0031 {PiO2-150)
 PiO2=0.21X(Pb-47)
 Similar corrections are also done, in other
scenarios .
Factors Affecting DLCO
 1. Haemoglobin and Haematocrit
 1g/dl decrease in Hb –DLCO reduces by 4 percent
 1g.dl Increase in Hb – DLCO increases by 2 %
 2.COHb
 Smokers-increase CoHb- decrease DLCO
 Each 1% increase- 1% decrease in DLCO
 3.Alveolar PCO2
 Increased PCO2-Increases DLCO
 4.Pulmonary Capillary Blood Volume
 Directly propotional
 Increase CO-exercise
 Pulmonary Haemorrhage
 5. Body Position
 Supine –increases
 6.Altitude Above Sea Level :
 High altitudes-higher DLCO
 7.Asthma and obesity
 Increased DLCO
 Enough explanations not available
Conditions Increasing Diffusing Capacity
 Polycythemia
 Obesity
 Asthma –usually when symptom free
 Pulmonary hemorrhage
 Supine Position
 Exercise
 Left to Right Shunt
Conditions Lowering Diffusing Capacity
 Decreased area for diffusion:
 Emphysema
 Lung Resection
 Bronchial Obstruction by tumour
 Anaemia
 Multiple Pulmonary Emboli
 Increased thickness of alveolar capillary membrane
 IPF
 CCF
 Asbestosis, Sarcoidosis
 Collagen Vascular diseases
 Drug Induced-
Amiodarone,nitrofurantoin,bleomycin,methotrexate
 Hypersensitivity pneumonitis
 Histiocytosis X
 Alveolar Proteinosis
CASE 1
 55 year old woman was referred with complaints of
Breathlessness on exertion.
 Smoking history of 38 packs years ,stopped 6 months ago
 Patient also has history of early morning cough with
expectoration
 Height :165 cms
 Weight-62.3 kgs
Pre bronchodilator
PREDICTED ACTUAL % PREDICTED
FVC 2.89 2.77 96
FEV1 2.30 1.91 83
PEF 6.08 4.01 66
PREDICTED % PREDICTED % CHANGE
FVC 2.82 98 2
FEV1 2.01 87 5
PEF 5.13 84 28
POST BRONCHODILATOR
Predicted Actual %predicted
TLC 4.39 4.97 113
FRC 2.45 3.10 127
RV 1.58 2.20 139
VC 2.89 2.77 96
IC 1.94 1.87 96
ERV 0.87 0.90 103
RV/TLC 36 44
PREDICTED ACTUAL % PREDICTED
DLCOsb (ml
CO/min/mm Hg)
19.7 10 51
Va 18.1 10 55
DL/Va 4.49 2.51 46
Hb 11
 1) What is the interpretation of PFT and
DLCO reports ??
 2)What other tests can be indicated ?
 3) What is the treatment recommendation?
 INTERPRETATIONS :
 FEV1 AND FVC –Normal
 Post bronchodilation :minimal change in FEV1 and FVC
 INCREASED –FRC and RV
 RV/TLC-Increased – AIR TRAPPING
 DLCO AND DL/Va reduced-Obstructive process
 Impression:
 Mild Obstruction with minimal response to bronchodilator
 Air trapping as suggested by DLCO reports
References
 Interpretation of Pulmonary Function Tests-
Robert E Hyatt and Paul Scanlon
 Ruppel’s Manual of Pulmonary Function Testing
 Fishman’s Textbook of Pulmonary Medicine
DLCO
DLCO

DLCO

  • 1.
  • 2.
    DLCO-Measures the efficiencyof lung in transporting oxygen across the alveolar capillary membrane Also known as Transfer Factor measurement of CO uptake reflects a no. of processes(not just diffusion) and it submaximal values ,hence its not truly a capacity Assessment of gas exchanging ability of the lung
  • 3.
    Carbon Monoxide DiffusingCapacity  Transfer of Carbon Monoxide – Diffusion Limited  Unit: ml of CO/minute/mm /Hg  0 degree Celsius,760 mm Hg ,dry  STPD-Standard Temperature Pressure Dry
  • 4.
    Why is COused ??  CO combines with Hb about 210 times more readily than oxygen  Diffusion Limited transfer  Limited/no CO in blood/alveoli
  • 5.
    Components of DiffusionPathway Gas space within the alveolus • Tissue barrier – alveolar capillary membrane • Alveolar lining fluid – surfactant rich • Plasma layer • Diffusion into and within the RBC • Uptake of CO by hemoglobin
  • 7.
  • 8.
  • 9.
    Methods Of DLCOmeasurement  1.Single breath Hold  2.Rebreathing Method  3.Intrabreath Method  4.Steady State Method
  • 10.
    Single Breath Hold–Modified Krogh’s  Before Starting the procedure :  A) Calibrate the equipment  B) Enter the necessary Data  C) Enter Hb levels  Place the Subject in sitting Down Position  Adjust the mouth piece to proper position  Seal the lips firmly around mouthpiece
  • 11.
    Indications Most commonly usedin evaluation of  diffuse interstitial lesions  suspected emphysema  pulmonary vascular obstruction  Monitoring of Drug Therapy –Amiodarone Useful in diagnosis as well as follow up
  • 12.
    Diffusing Capacity DLcosb Pretest PatientPreparation Should refrain from: Smoking for at least 24 hours prior to testing Consuming alcohol 4 hours prior to test (will reduce DLco) Strenuous exercise before testing (effects pulmonary capillary blood volume) Eating for at least two hours prior to testing (digestion effects pulmonary capillary blood volume)
  • 13.
    Diffusing Capacity Pretest PatientPreparation o Should sit for at least 5 minutes before test (effects pulmonary capillary blood volume) o Supplemental O2 should be discontinued at least five minutes prior to testing
  • 14.
    SINGLE BREATH METHOD Breathingmaneuvers reqd : Tidal breathing for few breaths Unforced expiration to RV Single forced inspiration. Breathhold for 8-12 sec Rapid expiration
  • 15.
    o Inspiratory gasmixture contain 0.3%CO and an inert gas 10%He. o Rapid exhalation time of <4sec &sample collection of no more than 3sec.are required. o Initial portion of expirate containing dead space is discarded ;remainder is collected & conc. of CO & He are measured.
  • 16.
    Procedure Unforced exhalation toRV (limited to 6 seconds) Rapid inhalation of a diffusion gas mixture to TLC (from spirometer/demand valve/reservoir) 0.3% CO 10% He (tracer gas) 21% O2 Balance Nitrogen Breath hold at TLC for 10 +/- 2 seconds Rapid exhalation (should not exceed 4 sec)
  • 17.
    Alveolar gas iscollected after a washout volume (0.75-1.0 L) has been discarded (If VC is <2.0 L, washout volume may be reduced to 0.50L) Sample gas volume should be 0.50 – 1.0 L (If VC <1.0L, a sample of <0.50L can be analyzed if deadspace volume has been cleared) Sample is analyzed for the fractional CO and He (tracer gas) concentration Change in He concentration reflects dilution by gas in lungs at RV This change is used to determine the initial CO concentration
  • 18.
    Summary of theprocedure Spirometry, lung volumes
  • 21.
    Acceptability Criteria 1.System has passedcalibration and quality control 2.Inspiration from RV to TLC –rapid and within four seconds 3.Inspired Volume-85 % of recorded VC 4.Breath Hold Time between 8- 12 seconds – no leaks , no Valsalva 5.Rapid Exhalation-lasting 4 or less seconds 6.Interval of 4 minutes between two episodes
  • 22.
    7.TLC and Vais consistent with clinical finding.Tlc should be always more than Va 8.Average of two or more tests should be reported Duplicate values should be within 3ml/min/mm Hg of each other or within 10 percentage of the largest value.
  • 23.
    Average DLco value 20-30ml CO/min/mm Hg (STPD)
  • 24.
    Inspiratory maneuver 14%He, 18%O2,0.27%CO) breathhold Deadspace washout(0.75 L) If VC<2L, reduce to 0.5L Sample collection volume 0.5-1LIf VC<2L, reduce to 0.5L
  • 25.
    Calculation of DLCO DLCO =VA X ln FACOi  T X (PB-47) FACOF T = time of breath hold PB = barometric pressure 47 = water vapour pressure at 37oC KCO = DLCO  VA VA=alv.vol FACOi=alv conc.@start of breath holding. FACOF=alv conc.@end of breath holding
  • 26.
    FACOi =FEHe/FIHe *FICO FEHe=expiredconc of He FIHe=inspired conc of He FICO=inspired conc of co FACO final is equal to conc of co in expired gas.
  • 27.
    Va alveolar volumeis determined in 2 ways: 1)Sum of RV calculated by closed circuit He or body plethysmography and vol of inspired gas as recorded on spirometer. 2)Calculated from single breath dilution of He that occur during determination of DLCO.
  • 28.
    Equipment quality control Gas-analyserzeroing Done before/after each test Volume accuracy Tested daily Standard subject or simulator testing Tested at least weekly Gas-analyser linearity Tested every 3 months Timer Tested every 3 months
  • 29.
    Severity for diffusiondisorders % of predicted Normal 80 – 100 Mild 60 – 79 Moderate 40 – 59 Severe 20 – 39 Very severe < 20
  • 30.
    STEADY STATE METHOD Inthis a gas mixture containing 0.1%CO is breathed until the rate of CO uptake from lung is constant. It require no respiratory manuveres and can be done during exercise. It require Arterial blood sample. It gives lower value for resting subjects than single breath method.
  • 31.
    Rebreathing Method  Patientis made to rebreathe from a reservoir containing 0.3 % CO, tracer gas and air  30-60 seconds at 30 breaths/min  Final CO,tracer and O2 concentrations are measured.
  • 32.
    Slow exhalation SingleBreath Intrabreath Method  Patient inspires a VC breath of test gas containing 0.3 % CO,21 % O2 and the balance N2  Patient exhales slowly – 0.5L/sec from TLC to RV.  CH4 used as the tracer gas
  • 34.
    Normal values ofDLCO and corrected DLCO  Normal Value: 20-30 ml CO/min/mm Hg  Normal Value depends on :  Age –decreases as age increases  Sex-lower in females  Size-taller people-larger lung –higher DLCO
  • 35.
     Alveolar volume-measuredwith the help of helium  DLCO/Va –normalizes the DLCO for various sizes  Also known as Krogh Constant
  • 36.
  • 37.
     2.Correction forCOHb : DLCO X (102 %-CoHb %)  3.Correction for altitude and PAO2  DLCO for altitude= DLCO /( 1+0.0031 {PiO2-150)  PiO2=0.21X(Pb-47)  Similar corrections are also done, in other scenarios .
  • 39.
    Factors Affecting DLCO 1. Haemoglobin and Haematocrit  1g/dl decrease in Hb –DLCO reduces by 4 percent  1g.dl Increase in Hb – DLCO increases by 2 %  2.COHb  Smokers-increase CoHb- decrease DLCO  Each 1% increase- 1% decrease in DLCO
  • 40.
     3.Alveolar PCO2 Increased PCO2-Increases DLCO  4.Pulmonary Capillary Blood Volume  Directly propotional  Increase CO-exercise  Pulmonary Haemorrhage
  • 41.
     5. BodyPosition  Supine –increases  6.Altitude Above Sea Level :  High altitudes-higher DLCO  7.Asthma and obesity  Increased DLCO  Enough explanations not available
  • 42.
    Conditions Increasing DiffusingCapacity  Polycythemia  Obesity  Asthma –usually when symptom free  Pulmonary hemorrhage  Supine Position  Exercise  Left to Right Shunt
  • 43.
    Conditions Lowering DiffusingCapacity  Decreased area for diffusion:  Emphysema  Lung Resection  Bronchial Obstruction by tumour  Anaemia  Multiple Pulmonary Emboli
  • 44.
     Increased thicknessof alveolar capillary membrane  IPF  CCF  Asbestosis, Sarcoidosis  Collagen Vascular diseases  Drug Induced- Amiodarone,nitrofurantoin,bleomycin,methotrexate  Hypersensitivity pneumonitis  Histiocytosis X  Alveolar Proteinosis
  • 46.
    CASE 1  55year old woman was referred with complaints of Breathlessness on exertion.  Smoking history of 38 packs years ,stopped 6 months ago  Patient also has history of early morning cough with expectoration  Height :165 cms  Weight-62.3 kgs
  • 47.
    Pre bronchodilator PREDICTED ACTUAL% PREDICTED FVC 2.89 2.77 96 FEV1 2.30 1.91 83 PEF 6.08 4.01 66 PREDICTED % PREDICTED % CHANGE FVC 2.82 98 2 FEV1 2.01 87 5 PEF 5.13 84 28 POST BRONCHODILATOR
  • 48.
    Predicted Actual %predicted TLC4.39 4.97 113 FRC 2.45 3.10 127 RV 1.58 2.20 139 VC 2.89 2.77 96 IC 1.94 1.87 96 ERV 0.87 0.90 103 RV/TLC 36 44
  • 49.
    PREDICTED ACTUAL %PREDICTED DLCOsb (ml CO/min/mm Hg) 19.7 10 51 Va 18.1 10 55 DL/Va 4.49 2.51 46 Hb 11
  • 50.
     1) Whatis the interpretation of PFT and DLCO reports ??  2)What other tests can be indicated ?  3) What is the treatment recommendation?
  • 51.
     INTERPRETATIONS : FEV1 AND FVC –Normal  Post bronchodilation :minimal change in FEV1 and FVC  INCREASED –FRC and RV  RV/TLC-Increased – AIR TRAPPING  DLCO AND DL/Va reduced-Obstructive process  Impression:  Mild Obstruction with minimal response to bronchodilator  Air trapping as suggested by DLCO reports
  • 52.
    References  Interpretation ofPulmonary Function Tests- Robert E Hyatt and Paul Scanlon  Ruppel’s Manual of Pulmonary Function Testing  Fishman’s Textbook of Pulmonary Medicine